$2,000

Raised to date of the $5,000,000 goal.
Investment Type: Regulation CF
Minimum Investment: $250

Boomerang is a digital health solution that prioritizes convenience and accuracy through state-of-the-art at-home diagnostic testing, customizable wellness plans, and strategic partnerships.


User convenience is the fundamental catalyst driving evolution within technology across all sectors. For decades, medical testing, and the healthcare industry at large, have been plagued by overly-complex systems, confusing information, and a common fear of blood draw. It’s time for a new approach to medical testing and healthcare that successfully prioritizes user convenience.



Offering at a Glance:
Highlights
Overview
How It Works
Business Model
Boomerang Membership
The Team
Frank Gianotti
CEO
Frank Gianotti’s 25 years in the entertainment industry and his track record of effective leadership have sharpened his instincts and..
Brian Hill
CFO
After relocating to California in 2004, Brian has worked as a tax supervisor, controller, and CFO. He has opened and managed several CP..
Dr. Billy Graves
Director
Using a patient-centric philosophy, Dr. Graves has dedicated the last 14 years to building an organization that offers every specialty ..
Dr. Ruben Gamez
Medical Director
Dr. Gamez is a Board Certified Pathologist with over 20 years of experience as a Medical Director. He has worked with companies such as..
William McDonald
Director
William McDonald serves as Managing Partner of the McDonald Family office which has invested over 85MM into the healthcare industry thr..
Q&A WITH FOUNDER

The leadership team at Boomerang represents an unlikely partnership between the entertainment industry and diagnostic science. COVID-19 brought many film and television productions to a stop with new health protocols needed to resume. Boomerang's CEO Frank Gianotti, whose background in TV and film connects him with many production studios and crew, saw a need for reliable testing services on set and facilitated medical staff and reporting for many productions throughout the pandemic. It was this opportunity that made Frank and his partners aware of the digital health sector and its ability to evolve and positively affect the overall healthcare industry which is plagued by overly-complex systems and leaves many feeling frustrated. Leadership at Boomerang are thrilled to offer accessible and controllable healthcare that prioritizes user convenience and encourages people of all ages, genders, and backgrounds to care for their health and well-being.

Boomerang is a digital health company focused on helping users monitor and care for their health by providing access to convenient at-home diagnostic test kits and customizable wellness plans. Users can order test kits directly to their home that support Men's Health, Women's Health, Sexual Health, and General Wellness. Once the kit arrives, users will find instructions for self-collecting their sample, registering their kit online with Boomerang's lab, and shipping their sample back for testing. When testing is complete, digital results are delivered to the user through a secure portal. Throughout the process, a wellness advisor from Boomerang will help guide the user as well as provide actionable next steps after results are available.

Our goal is to provide accessible and controllable healthcare through at-home diagnostic testing and customizable wellness plans based on results.

Boomerang is an at-home medical test kit developed by BioGnomics Lab. 

BioGnomics is CLIA-certified which is verifiable by our CLIA number. 

You can look up our lab on the CDC's laboratory search website by clicking here and entering our name and CLIA number 05D2198454. 

Please note: BioGnomics Lab does not offer any in-person testing appointments.

Term Sheets
Financial Discussion
Market Landscape
Risks & Disclosures
We have no operating history upon which you can evaluate our performance, and accordingly, our prospects must be considered in light of the risks that any new company encounters.We were incorporated under the laws of Delaware on October 24, 2022. Accordingly, we have no history upon which an evaluation of our prospects and future performance can be made. Our proposed operations are subject to all business risks associated with a new enterprise. T . . . . .
Read More
Form C

Boomerang Health Form C

Data Room
Updates

Boomerang Taps 5WPR as Agency of Record

Jan 19, 2023
NEW YORK, Jan. 18, 2023 /PRNewswire/ -- 5W Public Relations, one of the largest independently-owned PR firms in the U.S., ann..
Comments